Next, we knocked down CUL4B in CRC cells while simultaneously overexpressing either NSUN2‐WT or NSUN2‐DM and evaluated the changes in the ErbB signalling pathway and malignant phenotype of CRC cells. This evidence concerns the gene CUL4B and colorectal carcinoma.